His AIHealthTech Insider newsletter, issue 123, covers how a large group of women fared after half a year of virtual weight loss treatment.
Recap by typeshit. Post by Ramesh Dontha 🦉 on X.
He says close to 40% of weight lost in the trial's body-scan group was lean mass, and argues muscle loss isn't the drug's fault.
Wayne Pratt walks through what happens in the brain when drugs like Ozempic dial down the constant background chatter about eating.
Bikman cites a trial where people who lost about 21% and switched to placebo regained 14% within a year, while those who stayed on kept losing.
In Genome Medicine, diet-triggered delivery beat constant secretion on fat and liver fat, and kept down gut microbes carrying GLP-1-degrading peptidase genes.
The drug is still in clinical trials and lacks FDA approval, yet CBS News finds it promoted across the internet to people seeking weight loss.
A local event invites people to drop in and ask a PharmD about GLP-1 drugs. No location or details beyond the same-day timing.
Loading…